Authors

  • Фотима Бахтиёровна Ахмедова
  • Дилфуза Сабуровна Маткаримова
  • Кодиржон Тухтабоевич Бобоев

Keywords:

IL–6 – (C–174G), полиморфизм, провоспалительный цитокин, острый лейкоз, апоптоз, риск развития.

References

Bănescu C. еt al. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia //Cancer medicine. – 2019. – Т. 8. – №. 12. – С. 5492–5506.

Bharti R., Dey G., Mandal M. Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL–6 mediated involvement //Cancer letters. – 2016. – Т. 375. – №. 1. – С. 51–61.

Chonov D. C. et al. IL–6 activities in the tumour microenvironment. Part 1 //Open access Macedonian journal of medical sciences. – 2019. – Т. 7. – №. 14. – С. 2391.

Harun–Or–Roshid M. et al. Statistical meta–analysis to investigate the association between the Interleukin–6 (IL–6) gene polymorphisms and cancer risk //PloS one. – 2021. – Т. 16. – №. 3. – С. e0247055.

Kumari N. et al. Role of interleukin–6 in cancer progression and therapeutic resistance //Tumor Biology. – 2016. – Т. 37. – С. 11553–11572.

Liu R. T. et al. Correlations of IL–6 and IL–10 gene polymorphisms with childhood acute lymphoblastic leukemia //European Review for Medical & Pharmacological Sciences. – 2020. – Т. 24. – №. 15.

Liu T. Z. et al. Meta–analysis of the role of IL–6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies //Medicine. – 2017. – Т. 96. – №. 11. – С. e6126.

Nursal A. F. et al. The associations of IL–6, IFN–γ, TNF–α, IL–10, and TGF–β1 functional variants with acute myeloid leukemia in Turkish patients //Genetic testing and molecular biomarkers. – 2016. – Т. 20. – №. 9. – С. 544–551.

Rašková M. et al. The role of IL–6 in cancer cell invasiveness and metastasis—overview and therapeutic opportunities //Cells. – 2022. – Т. 11. – №. 22. – С. 3698.

Zhou L. et al. Associations of interleukin–6 gene polymorphisms with cancer risk: evidence based on 49,408 cancer cases and 61,790 controls //Gene. – 2018. – Т. 670. – С. 136–147.